Characteristics of Systematic Reviews on Oral Cancer Detection: A Protocol Analysis Based on PROSPERO

To understand the work described in this study, one must first understand how modern medical research tries to avoid getting lost in its own success. When scientists want to know if a treatment works or a disease can be caught early, they do not just read a few random papers; they perform a systematic review. This is a rigorous method where researchers gather every single piece of reliable evidence on a specific topic, check it for flaws, and combine the findings into one clear answer. Because this process is so powerful, it can change how doctors treat patients and how governments make health policies. However, for a review to be trustworthy, the researchers must write down their plan before they start looking for data. This plan, called a protocol, acts like a map that prevents them from changing the rules halfway through to fit a desired outcome. To keep these maps public and prevent different teams from wasting time doing the exact same work, scientists register their plans in a global database called PROSPERO. This system allows anyone to see what research is being planned, who is doing it, and how they intend to do it.

Oral cancer, a disease affecting the mouth and throat, is a significant global health challenge. It is the sixteenth most common cancer in the world, but in some regions, it is far more prevalent. Early detection is critical because finding the disease before it spreads dramatically improves a patient's chances of survival and quality of life. Researchers are constantly looking for better ways to spot these cancers early, using tools ranging from simple visual exams to complex molecular tests. To see how the scientific community is approaching this problem, a researcher named Aswin Kollamkandipalliyali examined the registered plans for 101 systematic reviews focused on detecting oral cancer. By analyzing these plans, the study reveals who is doing the research, what methods they are using, and where the field currently stands.

The analysis began by looking at 153 registered plans and narrowing them down to 101 that specifically focused on detecting oral cancer in humans. The researcher found that interest in this topic has grown steadily over the last decade, with a sharp rise in new plans starting in 2020. By August 2024, the vast majority of these plans, about 90 percent, were still in progress. Only five of the reviews had been completed and published in a scientific journal, while three more had finished their work but had not yet been published. This gap between registration and publication suggests that many researchers face delays, perhaps due to difficulties in gathering enough data or finding the time to finish the analysis. The study also noted that almost all of these reviews were written in English, and most were conducted by teams of two to seven people working together.

When the researcher looked at where these studies were coming from, a clear pattern emerged. India contributed the most plans, accounting for over a quarter of the total, followed by Brazil and China. This high level of activity from India is not surprising given that the country faces a very high rate of oral cancer, driven by lifestyle factors such as tobacco and betel nut use. The research came from 84 different institutions across 30 countries. The University of Santiago de Compostela in Spain had the most individual registrations, but Indian institutions were heavily represented among the top contributors. While most reviews were conducted by teams within a single country, a small number involved international collaboration, with India, Brazil, and the United States leading in these joint efforts.

The study also examined the tools and methods the researchers planned to use. Almost every review intended to look at how well different detection methods worked, with a heavy focus on biomarkers—substances in the body that can signal the presence of disease. Other common topics included artificial intelligence, vital staining, and standard screening tests. To ensure their results were trustworthy, the researchers planned to check the quality of the studies they included. The most popular tool for this was a specific checklist called QUADAS-2, which is designed to evaluate how well a study measures diagnostic accuracy. However, the study found a significant gap in transparency: while every plan said they would check for bias, many did not specify which tool they would use. Furthermore, a large number of plans did not clearly state how they would analyze the data or which software they would use. Only about 40 percent of the plans included a detailed description of how they would search for information, even though searching multiple databases is considered essential for a complete review.

The most commonly used database for these searches was PubMed, a free resource for medical literature, which appeared in nearly all the plans. Most researchers combined PubMed with other major databases like Scopus and Web of Science to ensure they did not miss any relevant studies. Despite the high number of plans, the study highlighted a concerning lack of funding. More than 70 percent of the reviews had no financial support, meaning the researchers were likely working on these projects without a dedicated budget. This financial strain, combined with the low completion rate, suggests that while the scientific community is eager to investigate oral cancer detection, many of these promising projects may struggle to reach completion without better support.

Ultimately, this analysis serves as a snapshot of a field in motion. It shows that while there is a strong global interest in finding better ways to detect oral cancer, particularly in countries where the disease is most common, the path from a registered plan to a finished, published review is often long and difficult. The study suggests that for the scientific community to make the most of its resources, researchers need to be more transparent about their methods and more consistent in finishing their work. By registering their plans, scientists have already taken the first step toward accountability, but the data indicates that more effort is needed to ensure these plans translate into finished research that can truly help patients.